🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 729139105
- IPO
- 6/3/2020 · $16.00/share
Business: Pliant Therapeutics, Inc. a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis
Company Contact
- CEO
- Bernard Coulie
- CFO
- Keith Cummings
- Headquarters
- 331 Oyster Point Boulevard, South San Francisco, CA
- Phone
- 650-481-6770
- Investor Relations
- Keith Cummings · 650-481-6770 · ir@pliantrx.com